Published in Hepatitis Weekly, August 29th, 2005
Study 1: Different enhancement agents reveal similar findings on liver MRI.
According to recent research published in the journal European Radiology, "the aim was to compare the diagnostic performance of dynamic Gd-DTPA- and ferumoxides-enhanced magnetic resonance imaging (MRI) for hepatocellular carcinoma (HCC). Twenty-five patients with chronic hepatitis or liver cirrhosis underwent both dynamic gadopentetate- and ferumoxides-enhanced MRI studies of the liver for HCC detection on the same day."
"MR data of both...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.